CLBT Stock Overview
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cellebrite DI Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.65 |
| 52 Week High | US$12.50 |
| 52 Week Low | US$5.51 |
| Beta | 1.51 |
| 1 Month Change | -0.65% |
| 3 Month Change | -9.21% |
| 1 Year Change | 88.50% |
| 3 Year Change | 7.36% |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?
May 21
Cellebrite: Big Fish In A Small Pond
Apr 29Recent updates
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?
May 21Cellebrite: Big Fish In A Small Pond
Apr 29Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce
Mar 14Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17
Feb 18There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price
Jan 28Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?
Nov 04Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)
May 26We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease
Apr 29Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?
Mar 16Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%
Feb 16Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?
Feb 09Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?
Oct 18Cellebrite: A Niche Company With A Large TAM
Sep 30Cellebrite DI Lowers Sights For 2022
Aug 30Cellebrite Non-GAAP EPS of $0.00 misses by $0.03, revenue of $62.6M misses by $6.5M
Aug 11Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price
Jul 08Shareholder Returns
| CLBT | US Software | US Market | |
|---|---|---|---|
| 7D | -4.1% | -4.7% | -0.6% |
| 1Y | 88.5% | 20.5% | 22.5% |
Return vs Industry: CLBT exceeded the US Software industry which returned 20.5% over the past year.
Return vs Market: CLBT exceeded the US Market which returned 22.5% over the past year.
Price Volatility
| CLBT volatility | |
|---|---|
| CLBT Average Weekly Movement | 4.5% |
| Software Industry Average Movement | 7.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CLBT has not had significant price volatility in the past 3 months.
Volatility Over Time: CLBT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,008 | Yossi Carmil | www.cellebrite.com |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations.
Cellebrite DI Ltd. Fundamentals Summary
| CLBT fundamental statistics | |
|---|---|
| Market cap | US$2.19b |
| Earnings (TTM) | -US$111.87m |
| Revenue (TTM) | US$329.25m |
6.6x
P/S Ratio-19.5x
P/E RatioIs CLBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLBT income statement (TTM) | |
|---|---|
| Revenue | US$329.25m |
| Cost of Revenue | US$40.21m |
| Gross Profit | US$289.04m |
| Other Expenses | US$400.90m |
| Earnings | -US$111.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 87.79% |
| Net Profit Margin | -33.98% |
| Debt/Equity Ratio | 0% |
How did CLBT perform over the long term?
See historical performance and comparison